Total Funding
19
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
XTENT is a development stage medical device company.
Randy Campbell: CTO
About the Company
Xtent is a development stage medical device company focused on developing and commercializing their innovative customizable drug eluting stent systems for the treatment of coronary artery disease, or CAD. Their drug eluting stent systems are designed to enable physicians to customize both length and diameter of the stent at the site of the diseased
section of the artery, or lesion, which we refer to as in-situ customization.
